COMPUTATION OF NET INCOME (LOSS) PER SHARE
Published on
EXHIBIT 11.1
SONUS PHARMACEUTICALS, INC.
COMPUTATION OF NET INCOME (LOSS) PER SHARE
<TABLE>
<CAPTION>
THREE MONTHS ENDED
MARCH 31,
-----------------------------
BASIC EARNINGS PER SHARE: 1998 1997
----------- -----------
<S> <C> <C>
Net income (loss) .................... $(3,266,692) $ 1,356,187
Weighted average common shares ....... 8,612,923 8,531,352
Basic earnings per share .......... $ (0.38) $ 0.16
DILUTED EARNINGS PER SHARE:
Net income (loss) .................... $(3,266,692) $ 1,356,187
Weighted average common shares - basic 8,612,923 8,531,352
Dilutive potential common shares ..... -- 965,730
----------- -----------
Total ............................. 8,612,923 9,497,082
=========== ===========
Diluted earnings per share ........ $ (0.38) $ 0.14
</TABLE>
13